Full Width 
Shortcuts 
Sign Up 
Log In 
Articles 
Reading List More from Ed Zitron's Where's Your Ed At
In the last week, we’ve had no less than three different pieces asking whether the massive proliferation of data centers is a massive bubble, and though they, at times, seem to take the default position of AI’s inevitable value, they’ve begun to sour on
Hello and welcome to the latest premium edition of Where's Your Ed At, I appreciate any and all of your subscriptions. I work very hard on these, and they help pay for the costs of running Ghost and, well, my time investigating different things. If you're
Earlier in the week, the Wall Street Journal reported that SoftBank and OpenAI's "$500 billion" "AI Project" was now setting a "more modest goal of building a small data center by year-end." To quote: A $500 billion effort unveiled at the White
Hey! Before we go any further — if you want to support my work, please sign up for the premium version of Where’s Your Ed At, it’s a $7-a-month (or $70-a-year) paid product where every week you get a premium newsletter, all while supporting my free
Hello premium subscribers! Today I have the first guest post I've ever commissioned (read: paid) on Where's Your Ed At - Nik Suresh, one of the greatest living business and tech writers, best-known for his piece I Will Fucking Piledrive You If You Mention AI Again
More in startups
The Gulf nation offers advanced software without fees or restrictions, positioning itself as a neutral tech power between the U.S. and China.
mRNA promised to help turn cancer from a death sentence into a manageable condition.
Google and Perplexity are offering free access to their AI-powered search in India, a key testing ground and source of training data for AI models.
In the last week, we’ve had no less than three different pieces asking whether the massive proliferation of data centers is a massive bubble, and though they, at times, seem to take the default position of AI’s inevitable value, they’ve begun to sour on
Multibillion-dollar partnerships show China’s rising influence in AI-driven pharmaceuticals.
